Lei Wang

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
A CXCR4/PD-L1 Bispecific Nanobody Engineered for Tumor Microenvironment Retention Mediates Sustained Synergy with Chemotherapy via Remodeling Immunity in TNBC.

|Feb 05, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.

Yunji Liao, Hang Ma, Zhenyu Wang

|Feb 10, 2024
Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.

Jingyi Bai, Xi Li, Jun Zhao

|Dec 23, 2023
Generation and Characterization of SORT1-Targeted Antibody-Drug Conjugate for the Treatment of SORT1-Positive Breast Tumor.

Weiliang Zhuang, Wei Zhang, Liping Xie

|Nov 25, 2023
Generation of a Novel SORT1×HER2 Bispecific Antibody-Drug Conjugate Targeting HER2-Low-Expression Tumor.

Weiliang Zhuang, Wei Zhang, Lei Wang

Pageof 1

Frequent Collaborators

4 joint publications

Baohong Zhang

3 joint publications

Jianwei Zhu

1 joint publications

Huifang Zong

1 joint publications

Buyong Ma